Patent 8015006

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-flash

Proceedings on file (1)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

1 discretionary denial
Discretionary Denial
Filed
Aug 15, 2025
Last modified
Mar 4, 2026
Petitioner
Meta Platforms, Inc.
Inventor
Robert A. Kennewick et al

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings overview

There is one AIA trial proceeding on file for US Patent 8,015,006, which concluded with a discretionary denial of institution. This means the patent's claims remain untested by a full IPR trial, suggesting a defendant would face an unhardened patent in litigation.

IPR2025-01335 — Meta Platforms, Inc. v. Dialect LLC

  • Type: Inter Partes Review
  • Filed: 2025-08-15
  • Status: Discretionary Denial. This means the PTAB declined to institute the IPR, preventing the trial from moving forward on its merits.
  • Judge panel: Administrative Patent Judges S. H. Kim, P. L. Kim, and S. M. Kim.
  • Petition grounds: The petition challenged claims 1-20 of U.S. Patent No. 8,015,006 B2, alleging obviousness under 35 U.S.C. § 103 over combinations of prior art references including U.S. Patent No. 6,654,740 (Tokuda) and U.S. Patent No. 6,434,524 (Kanevsky).
  • Institution decision: Denied on 2026-03-04. The Board exercised its discretion under 35 U.S.C. § 314(a) and Fintiv factors to deny institution, citing parallel district court litigation involving the same patent. Specifically, the Board noted that the petitioner (Meta) had been sued for infringement of the patent in the Western District of Texas (Case No. 7:25-cv-00061), and that the petition was filed shortly after the answer in the district court action. The Board found that the district court trial date was set for June 2026, which was before the PTAB's statutory deadline for a Final Written Decision (August 2026), and that the issues in the IPR substantially overlapped with the district court case.
  • Final Written Decision: Not applicable; institution was denied.
  • Settlement / termination: Not applicable; institution was denied.
  • Appeal: Not appealed.
  • Defensive value: This proceeding indicates that the claims of US 8,015,006 have not been fully reviewed on their merits by the PTAB. While Meta attempted to challenge claims 1-20, the denial was based on procedural grounds (Fintiv factors due to parallel litigation) rather than the merits of the prior art. Therefore, a new defendant facing assertion of this patent may still be able to pursue IPR challenges, provided they can address the Fintiv factors (e.g., by filing earlier in relation to litigation or by demonstrating less overlap, if applicable).

Strategic summary

All claims (1-20) of US 8,015,006 are currently UNTESTED by a full IPR trial. The sole IPR proceeding, IPR2025-01335, was denied institution based on the PTAB's discretionary authority under the Fintiv factors, primarily due to parallel district court litigation with a trial date preceding the IPR's Final Written Decision deadline. This means no claims were invalidated or sustained on the merits through this PTAB process.

The estoppel landscape for IPR2025-01335 is limited. Since the IPR was denied institution, statutory estoppel under 35 U.S.C. § 315(e)(2) for grounds that could have been raised is generally not triggered for the petitioner (Meta Platforms, Inc.) or their privies. However, grounds actually raised in the petition and rejected during the institution phase might face some form of non-statutory or common law estoppel in future proceedings, although this is less definitive than statutory estoppel from a Final Written Decision. For other defendants not in privity with Meta, the prior art raised in IPR2025-01335 (Tokuda, Kanevsky, and combinations thereof) remains available for use in district court litigation or new IPR petitions, subject to meeting institution thresholds.

The denial based on Fintiv factors suggests that patent owner, Dialect LLC, successfully leveraged the timing and overlap with district court litigation to avoid PTAB scrutiny of the patent's validity. This indicates a strategy by the patent owner to litigate in district court rather than face parallel PTAB challenges.

Recommended next steps

If you are a defendant currently facing assertion of US 8,015,006, it is important to understand that the patent's claims have not been substantively reviewed by the PTAB. The institution denial for IPR2025-01335 on Fintiv grounds means that the merits of the obviousness challenge were not addressed.

  • Review IPR2025-01335 Institution Decision: Carefully examine the PTAB's institution decision in IPR2025-01335 to understand the specific Fintiv factors that led to the discretionary denial. This will be crucial if considering a new IPR filing.
  • Evaluate New IPR Petition Strategy: If considering filing your own IPR, assess whether the Fintiv issues (e.g., timing relative to district court litigation, overlap with district court issues) can be mitigated. Filing an IPR before district court litigation is advanced, or demonstrating distinct issues, could improve chances of institution. The prior art cited in IPR2025-01335, as well as other potential prior art, remains available for challenge.
  • Assess Patent Strength: Since the patent's claims have not been validated or invalidated by the PTAB, a thorough independent analysis of the patent's validity over all relevant prior art (including that cited in IPR2025-01335) is highly recommended.
  • Monitor Litigation: Keep an eye on the ongoing district court litigation in the Western District of Texas (Case No. 7:25-cv-00061) involving this patent, as its outcome could provide further insights into the patent's strength and the patent owner's strategy.

Generated 5/22/2026, 6:47:15 AM